-- Israeli Stocks: Elbit Imaging, Teva, Flowsense, Delek Group
-- B y   S h o s h a n n a   S o l o m o n
-- 2012-01-04T15:50:31Z
-- http://www.bloomberg.com/news/2012-01-04/israeli-stocks-elbit-imaging-teva-flowsense-delek-group.html
Israel ’s  TA-25 Index (TA-25)  rose for a
fourth day, advancing 0.1 percent to 1,111.53, at the 4:30 p.m.
close in  Tel Aviv . The measure dropped 18 percent last year.
Investors traded about 1.2 billion shekels ($311 million) of
shares and convertible securities, according to bourse data.  The following stocks rose or fell today. Symbols are in
parenthesis.  Biondvax Pharmaceuticals Ltd. (BNDX)  , a developer of
intra-nasal flu vaccines, soared the most since Sept. 7,
advancing 6.6 percent to 1.69 shekels. Twelve people in five
U.S. states have been infected with a new flu virus, according
to the Centers for Disease Control and Prevention in Atlanta.  Elbit Imaging Ltd. (EMIT)   surged to the highest level
since Dec. 14, gaining 6.9 percent to 10.80 shekels. Calcalist
reported that the investor in real estate and medical companies
is in talks to sell its holdings in U.S. malls to Blackstone
Group LP. A message left for a spokeswoman for Elbit Imaging
wasn’t returned.  Delek Group Ltd. (DLEKG)   gained the most since Dec. 20,
climbing 2.5 percent to 725.80 shekels. The holding company was
initiated with a “buy” recommendation at UBS AG.  D. Medical Industries Ltd. (DMED)  (DMED IT) advanced 2.5 percent,
the most since Nov. 30, to 5.27 shekels, giving the Tirat
Carmel, Israel-based company a market value of 43 million
shekels. The maker of drug-delivery devices said its infusion
set was listed in a U.S. diabetes consumer guide.  Flowsense Medical Ltd. (FLSN)   surged the most since Oct.
5, advancing 9.1 percent to 0.084 shekel. The maker of an
automated urine-monitor system signed a memorandum of
understanding with a U.S. distributor for the marketing of its
URINFO 2000 system.  Space Communication Ltd. (SCC)   gained 2.1 percent to
69.52 shekels, the highest since April 11. The supplier of
satellite communication services said the Amos 5 satellite has
reached its space slot.  Teva Pharmaceutical Industries Ltd. (TEVA)   rose to the
highest level since July 14, advancing 3.2 percent to 165.90
shekels, or the equivalent of $43.05. The shares of the world’s
largest generic drugmaker advanced on reports Ranbaxy
Laboratories Ltd. gained Lipitor market share and as analysts
applauded the company’s choice of chief executive officer.  To contact the reporter on this story:
Shoshanna Solomon in Tel Aviv at 
 ssolomon22@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  